During the past decade, The Fourth Affiliated Hospital of China Medical University conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 2 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Fourth Affiliated Hospital of China Medical University" #1 sponsor was "Shengjing Hospital" with 3 trials, followed by "Xueying Yang" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Shenyang Northern Hospital" with 2 trials sponsored and "Chengdu Kanghong Biotech Co., Ltd." with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Fourth Affiliated Hospital of China Medical University" #1 collaborator was "Incyte Corporation" with 2 trials as a collaborator, "Ankang City Central Hospital" with 1 trials as a collaborator, "Beihua University" with 1 trials as a collaborator, "Beijing Chuiyangliu Hospital(Beijing Minimally Invasive Hospital)" with 1 trials as a collaborator and "Beijing Shijitan Hospital,the 9th Clinical Medical College of Peking university" with 1 trials as a collaborator. Other collaborators include 53 different institutions and companies that were collaborators in the rest 63 trials.

According to Clinical.Site data, the most researched conditions in "The Fourth Affiliated Hospital of China Medical University" are "Breast Cancer" (2 trials), "Systemic Lupus Erythematosus" (2 trials), "Acute ST Segment Elevation Myocardial Infarction" (1 trials), "Adverse Drug Reaction" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "The Fourth Affiliated Hospital of China Medical University" in a lesser frequency.

Most popular intervention types in "The Fourth Affiliated Hospital of China Medical University" are "Drug" (8 trials), "Procedure" (4 trials), "Other" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (2 trials), "Placebo" (2 trials), "Albumin-bound paclitaxel combined with carboplatin" (1 trials), "Anterior transversalis fascia approach" (1 trials) and "Aromasin (exemestane)" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Fourth Affiliated Hospital of China Medical University" are 12 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Fourth Affiliated Hospital of China Medical University". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in The Fourth Affiliated Hospital of China Medical University, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in The Fourth Affiliated Hospital of China Medical University, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".